Skip to content

The study on the acupuncture in treating Insomnia associated with chronic gastritis by the theroy of "Tiaodu Hewei": a randmized controlled trial

The study on the acupuncture in treating Insomnia associated with chronic gastritis by the theroy of "Tiaodu Hewei": a randmized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003726
Enrollment
Unknown
Registered
2020-08-26
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia associated with chronic gastritis

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) It conforms to the above diagnostic criteria of western medicine and Chinese medicine for chronic gastritis and insomnia, and insomnia is secondary to chronic gastritis; (2) The age range is between 18 and 65 years old, without limitation to men or women; (3) PSQI rating is ok and average; (4) Duration of insomnia >= 1 month; (5) Be able to understand the provisions of various daytime functional scales and complete the assessment; (6) Agree to participate in the investigation and sign written informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe gastric and/or duodenal ulcers and pathological diagnosis of suspected malignant transformation; (2) Patients with severe primary or concurrent diseases such as heart, brain, kidney, liver and hematopoietic system; (3) Patients with systemic diseases such as pain, fever, cough, surgery and secondary insomnia caused by external environmental interference factors; (4) women who are pregnant, breast-feeding or preparing for pregnancy; (5) The patient had received other relevant treatments (such as diazepam, alprazolam and other drugs) within the last 2 weeks, which affected the efficacy The observer; (6) Patients with severe mental diseases such as schizophrenia; (7) Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index, PSQI;

Secondary

MeasureTime frame
SDS;wActiSleep-BT;Insomnia Severity Index, ISI;PRO;TCM syndrome score scale;

Countries

China

Contacts

Public ContactYin Ping

Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine

bingxue616@163.com+86 18917561621

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026